Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02233790Phase 4Unknown
A Phase 4 trial of ticagrelor in myocardial infarction (MI), no-reflow phenomenon, sponsored by First Hospital of China Medical University. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02233790.